PEPTIDES DERIVED FROM THE ONCOGENE PROTEINE BCR-ABL EXPRESSED BY LEUKEMIC CELLS AND UTILISATION THEREOF FOR THE THERAPY OF HUMAN LEUKEMIAE
摘要
<p>The invention relates to peptides capable of inducing a response of human cytotoxic T lymphocytes (CTL) specifically directed against cells expressing the fusion protein BCR-ABL.</p>
